TOI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $312,277.74

Oncology Institute Insider Trading History Chart

Oncology Institute Share Price & Price History

^$1.18

▼ -0.02 (-1.67%)

As of 04/25/2024 01:00 AM ET

Days: 30 | 90 | 365

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

Oncology Institute Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/29/2024	Havencrest Healthcare Partners	Major Shareholder	Sell	8,637	$2.12	$18,310.44
1/26/2024	Havencrest Healthcare Partners	Major Shareholder	Sell	6,979	$2.14	$14,935.06	8,637
1/24/2024	Havencrest Healthcare Partners	Major Shareholder	Sell	24,915	$2.30	$57,304.50	27,498
1/22/2024	Havencrest Healthcare Partners	Major Shareholder	Sell	10,263	$2.12	$21,757.56	57,751
1/19/2024	Havencrest Healthcare Partners	Major Shareholder	Sell	11,986	$2.13	$25,530.18	68,014
11/17/2023	Brad Hively	Director	Sell	25,000	$2.24	$56,000.00	697,065
11/13/2023	Brad Hively	Director	Sell	47,000	$2.52	$118,440.00	724,182
3/17/2023	Richard A Barasch	Director	Buy	50,000	$0.55	$27,500.00	257,193
12/16/2022	Matthew P Miller	COO	Buy	73,684	$0.95	$69,999.80	175,325
11/14/2022	Mohit Kaushal	Director	Sell	15,994	$2.13	$34,067.22	25,534
11/11/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	365,321	$2.33	$851,197.93	13,362,873
11/9/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	80,000	$3.09	$247,200.00	13,789,475
11/7/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	19,167	$3.28	$62,867.76	13,896,475
11/4/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	50,200	$3.39	$170,178.00	13,915,642
11/2/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	58,500	$3.94	$230,490.00	14,011,342
10/31/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	41,855	$4.69	$196,299.95	14,120,114
10/28/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	52,091	$4.84	$252,120.44	14,161,969
10/26/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	52,500	$5.16	$270,900.00	14,249,060
10/24/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	29,400	$4.98	$146,412.00	14,331,960
10/24/2022	Mohit Kaushal	Director	Sell	4,798	$4.96	$23,798.08	41,528
10/20/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	12,000	$4.83	$57,960.00	14,381,360
10/17/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	8,249	$4.60	$37,945.40	14,423,060
10/14/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	9,800	$4.54	$44,492.00	14,431,309
10/12/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	14,343	$4.70	$67,412.10	14,466,309
10/10/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	21,500	$4.33	$93,095.00	14,505,652
10/7/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	14,652	$4.63	$67,838.76	14,527,152
10/5/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	14,060	$4.78	$67,206.80	14,575,313
10/3/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	16,765	$4.72	$79,130.80	14,612,820
9/30/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	11,000	$4.68	$51,480.00	14,629,585
9/28/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	12,642	$4.72	$59,670.24	14,661,585
9/26/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	7,153	$4.57	$32,689.21	14,688,301
9/22/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	13,086	$4.25	$55,615.50	14,700,829
9/19/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	19,629	$4.33	$84,993.57	14,713,915
9/16/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	200,000	$4.50	$900,000.00	14,733,544
9/14/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	37,785	$4.99	$188,547.15	15,002,044
9/12/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	38,000	$5.52	$209,760.00	15,092,329
9/9/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	18,900	$5.80	$109,620.00	15,130,329
9/7/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	45,000	$6.04	$271,800.00	15,172,729
8/31/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	25,000	$6.36	$159,000.00	15,375,212
8/29/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	15,000	$6.14	$92,100.00	15,438,712
8/26/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	40,000	$6.03	$241,200.00	15,453,712
8/24/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	21,084	$6.37	$134,305.08	15,497,237
8/22/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	35,500	$6.53	$231,815.00	15,566,421
8/19/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	10,873	$6.81	$74,045.13	15,601,921
8/15/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	16,663	$6.23	$103,810.49	15,621,231
8/12/2022	Havencrest Healthcare Partners	Major Shareholder	Sell	24,900	$6.69	$166,581.00	15,637,894
5/11/2022	Richy Agajanian	Major Shareholder	Sell	1,600,000	$6.00	$9,600,000.00	253,436

These AI trades triggered this morning (545% return)

From Prosper Trading Academy | Ad

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

SEC Filings (Institutional Ownership Changes) for Oncology Institute (NASDAQ:TOI)

36.86% of Oncology Institute stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Oncology Institute Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Quattro Financial Advisors LLC	55,960	$88K	0.0%	N/A	0.075%
2/14/2024	Kent Lake Capital LLC	1,085,171	$2.21M	0.9%	+492.3%	1.471%
2/13/2024	Tower Research Capital LLC TRC	12,046	$25K	0.0%	N/A	0.016%
2/8/2024	Cincinnati Insurance Co.	699,500	$1.43M	0.0%	N/A	0.948%
2/7/2024	Josh Arnold Investment Consultant LLC	1,856,329	$3.79M	3.7%	-1.1%	2.517%
2/6/2024	Fielder Capital Group LLC	70,192	$0.14M	0.1%	N/A	0.095%
1/23/2024	WealthShield Partners LLC	24,126	$49K	0.0%	N/A	0.033%
1/1/2024	Vanguard Group Inc.	1,758,034	$2.46M	0.0%	-0.3%	2.384%
11/22/2023	Josh Arnold Investment Consultant LLC	1,877,472	$2.65M	2.8%	+77.4%	2.546%
11/15/2023	Kent Lake Capital LLC	183,215	$0.26M	0.1%	N/A	0.251%
11/14/2023	Saba Capital Management L.P.	94,264	$0.13M	0.0%	-44.7%	0.129%
11/8/2023	Vanguard Personalized Indexing Management LLC	21,269	$30K	0.0%	N/A	0.029%
11/8/2023	Tiff Advisory Services LLC	423,405	$0.59M	0.5%	N/A	0.580%
9/7/2023	Triatomic Management LP	904,689	$0.50M	0.5%	+11.7%	1.240%
8/14/2023	Prosight Management LP	455,302	$0.25M	0.1%	+61.5%	0.604%
5/3/2023	Triatomic Management LP	810,145	$0.55M	0.4%	+56.6%	1.087%
2/16/2023	Josh Arnold Investment Consultant LLC	104,400	$0.17M	0.3%	N/A	0.140%
2/14/2023	Triatomic Management LP	517,479	$0.85M	0.7%	+41.5%	0.695%
11/16/2022	Saba Capital Management L.P.	348,059	$1.61M	0.0%	-5.2%	0.475%
11/15/2022	Parian Global Management LP	240,724	$1.12M	3.6%	+31.0%	0.329%
11/8/2022	New York State Common Retirement Fund	10,974	$51K	0.0%	-30.5%	0.015%
10/26/2022	Allspring Global Investments Holdings LLC	10,919	$50K	0.0%	N/A	0.015%
8/16/2022	Parian Global Management LP	183,828	$0.93M	4.3%	-58.6%	0.251%
8/16/2022	Deerfield Management Company L.P. Series C	3,383,099	$17.12M	0.4%	+2.6%	4.617%
5/17/2022	Empery Asset Management LP	70,733	$0.50M	2.4%	-64.6%	0.097%
5/12/2022	Triatomic Management LP	428,100	$3.05M	2.5%	+7.0%	0.584%
5/9/2022	Qube Research & Technologies Ltd	37,850	$0.27M	0.0%	+102.5%	0.052%
2/15/2022	Saba Capital Management L.P.	400,000	$3.73M	0.1%	N/A	1.391%
2/14/2022	Parian Global Management LP	466,676	$4.55M	3.7%	N/A	1.623%
2/14/2022	Redmile Group LLC	2,500,000	$24.38M	0.6%	N/A	8.696%
2/14/2022	Deerfield Management Company L.P. Series C	3,296,107	$32.14M	0.7%	N/A	11.465%
2/10/2022	Qube Research & Technologies Ltd	18,688	$0.18M	0.0%	N/A	0.065%

Data available starting January 2016

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Today's Range

Now: $1.18

$1.17

$1.29

50 Day Range

MA: $1.57

$1.13

$1.95

52 Week Range

Now: $1.18

$0.33

$2.66

Volume

58,372 shs

Average Volume

93,066 shs

Market Capitalization

$87.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.68

Who are the company insiders with the largest holdings of Oncology Institute?: Oncology Institute's top insider shareholders include:
Havencrest Healthcare Partners (Major Shareholder)
Brad Hively (Director)
Richard A Barasch (Director)
Richy Agajanian (Major Shareholder)
Matthew P Miller (COO)
Mohit Kaushal (Director)
Learn More about top insider investors at Oncology Institute.
Who are the major institutional investors of Oncology Institute?: Oncology Institute's top institutional investors include:
Quattro Financial Advisors LLC — 0.08%
Learn More about top institutional investors of Oncology Institute stock.
Which institutional investors are buying Oncology Institute stock?: In the previous quarter, TOI stock was purchased by institutional investors including:
Quattro Financial Advisors LLC
In the previous year, these company insiders have bought Oncology Institute stock:
Havencrest Healthcare Partners (Major Shareholder)
Brad Hively (Director)
Learn More investors buying Oncology Institute stock.